NIH #U01CA263986
Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients
Active
- Amount
- $300K–$400K
- Period
- 2023-08-01 → 2027-11-30
- PIs
- 1
Michael H. A. Roehrl
Full Professor(heuristic)
Cancer Genomics and Diagnostics · Cancer Research
Compare more Cancer Research professors.
h-index52
i10-index110
Publications208
Citations27,338
Grants
4 total · 1 active
NIH #R21CA263262
Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic Progression
- Amount
- $200K–$300K
- Period
- 2021-08-20 → 2025-07-31
- PIs
- 1
NIH #P30CA008748
Pathology
- Amount
- $700K–$800K
- Period
- 1997-01-20 → 2023-12-31
- PIs
- 1
Awarded at SLOAN-KETTERING INST CAN RESEARCH
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies (Cancer Research)2026-07-02
- New preprint: Proteogenomic profiling of soft tissue leiomyosarcoma reveals distinct molecular subtypes with divergent outcomes and therapeutic vulnerabilities2025-11-24
- New NIH award: Evaluation of Patient Factors and Sample Pre-Analytics on Predictive Multiplex Immunohistochemical Assays in Immuno-Oncology Patients2023-08-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0003-4892-1098